查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1358084

抗真菌藥物市場：按藥物類型、按適應症、按劑型、按配銷通路、按地區

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2023 年，全球抗真菌藥物市場價值將達到 140 億美元，預測期內（2023-2030 年）年複合成長率為 3.5%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 140億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 3.50% 2030年市場規模預測 178億美元
抗真菌藥物全球市場佔有率(%)（按藥物類型），2023 年
抗真菌藥物市場-IMG1

抗真菌藥物是選擇性消除宿主真菌病原體同時將對宿主的毒性降至最低的藥物。抗真菌藥物治療真菌感染疾病。土壤、空氣和皮膚中存在的真菌可引起酵母菌感染疾病、癬以及指甲和皮膚感染疾病。吸入真菌孢子會導致呼吸道疾病。真菌感染疾病會影響循環系統、呼吸系統、皮膚和指甲。抗真菌藥物可以殺死真菌。抗真菌藥物可以殺死真菌或阻止其繁殖或生長。抗真菌藥物有多種類別和不同類型。使用抗真菌藥物治療的常見真菌感染疾病包括癬、足癬、指甲真菌感染疾病、陰道鵝口瘡和嚴重類型的頭皮屑。抗真菌藥物以兩種方式發揮作用：直接殺死真菌細胞，並阻止真菌細胞生長或繁殖。抗真菌藥物可以在不損害人體細胞的情況下對抗真菌感染，因為它們針對的是真菌細胞所需的結構和功能，而不是人體細胞所需的結構和功能。兩種常見的目標結構是真菌細胞膜和真菌細胞壁。兩者都是圍繞和保護真菌細胞的結構。如果其中任何一個受到損壞，真菌細胞就會破裂並死亡。

市場動態

市場主要參與者增加產品推出預計將在預測期內推動全球抗真菌藥物市場的成長。例如，2022年4月，製藥公司Dr. Reddy's Laboratories宣佈在美國市場推出泊沙康唑延遲釋放片。泊沙康唑用於預防免疫力嚴重衰弱的患者（例如接受化療的患者）的某些真菌感染。有一類藥物稱為唑類抗真菌藥物。它的作用是抑制真菌的生長。

本研究的主要特點

  • 本報告詳細分析了全球抗真菌藥物市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和複合年度（年複合成長率）。它還強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球抗真菌藥物市場的主要參與者進行了分析。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 全球抗真菌藥物市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
  • 相關人員可以透過用於分析全球抗真菌藥物市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 最近測試啟動
  • 流行病學
  • 合併、收購和合作
  • 法規場景
  • 主要進展
  • PEST分析

第4章 全球抗真菌藥物市場－新型冠狀病毒感染疾病（COVID-19）影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球抗真菌藥物市場：依藥物類型，2018-2030

  • 棘白菌素
  • 多烯
  • 烯丙胺
  • 亞佐爾
  • 其他

第6章 全球抗真菌藥物市場：依適應症分類，2018-2030

  • 麴菌病
  • 皮膚絲狀菌症
  • 念珠菌病
  • 毛黴菌病
  • 其他

第7章 全球抗真菌藥物市場：按劑型，2018-2030

  • 粉末
  • 軟膏
  • 注射
  • 錠劑
  • 其他

第8章 全球抗真菌藥物市場：依配銷通路分類，2018-2030

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 全球抗真菌藥物市場：按地區分類，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭形勢

  • 公司簡介
    • GlaxoSmithKline Plc
    • Bayer AG
    • Abbott Laboratories
    • Merck &Co., Inc
    • Glenmark Pharmaceuticals Limited
    • Enzon Pharmaceuticals, Inc
    • Pfizer Inc
    • Gilead Sciences, Inc
    • Sanofi SA
    • Astellas Pharma, Inc
    • Alembic Pharmaceuticals Limited
    • SCYNEXIS, Inc

第11章章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI237

The global anti fungal drugs market is estimated to be valued at US$ 14.0 billion in 2023 and is expected to exhibit a CAGR of 3.5% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 14.0 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 3.50% 2030 Value Projection: US$ 17.8 Bn
Global Anti Fungal Drugs Market Share (%), By Drug Type, 2023
Anti Fungal Drugs Market - IMG1

An antifungal agent is a drug that selectively eliminates fungal pathogens from a host with minimal toxicity to the host. Antifungal medicines treat fungal infections. Fungus in the soil, air, and on the skin can cause yeast infections, ringworm, and nail and skin infections. Breathing in fungal spores can lead to respiratory illnesses. Fungal infections can affect the circulatory system, respiratory system, and the skin and nails. Antifungal medicines can kill a fungus. Or they may stop it from multiplying or growing. There are several classes of antifungal medications and different types of medicines. Common fungal infections treated with anti-fungal medication include ringworm, athlete's foot, fungal nail infection, vaginal thrush, severe type of dandruff, and others. Antifungal drugs can work in two ways: by directly killing fungal cells or by preventing fungal cells from growing and thriving. Antifungal drugs target structures or functions that are necessary in fungal cells but not in human cells, so they can fight a fungal infection without damaging the body's cells. Two structures that are commonly targeted are the fungal cell membrane and the fungal cell wall. Both of these structures surround and protect the fungal cell. When either one becomes compromised, the fungal cell can burst open and die.

Market Dynamics

Increasing product launches by the key players in the market are expected to drive the growth of the global anti fungal drugs market over the forecast period. For instance, in April 2022, Dr. Reddy's Laboratories, a pharmaceutical company, announced the launch of the Posaconazole delayed-release tablets in the U.S. market. Posaconazole is used to prevent certain fungal infections in patients who have severely weakened immune systems (such as patients who have had chemotherapy). It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.

Key features of the study:

  • This report provides an in-depth analysis of the global anti fungal drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti fungal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Te key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc., Alembic Pharmaceuticals Limited, and SCYNEXIS, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global anti fungal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti fungal drugs market

Detailed Segmentation:

  • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
  • By Application:
    • Neurosurgery
    • Plastic Surgery
    • Cardiovascular Surgery
    • Obstetrics & Gynecology
    • Others
  • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Mucormycosis
    • Others
  • By Dosage Form :
    • Powders
    • Ointments
    • Injections
    • Tablets
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • GlaxoSmithKline Plc.
    • Bayer AG
    • Abbott Laboratories
    • Merck & Co., Inc
    • Glenmark Pharmaceuticals Limited
    • Enzon Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Gilead Sciences, Inc.
    • Sanofi S.A.
    • Astellas Pharma, Inc.
    • Alembic Pharmaceuticals Limited
    • SCYNEXIS, Inc

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Indication
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Anti Fungal Drugs Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Anti Fungal Drugs Market, By Drug Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Echinocandins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Polyenes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Allylamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Azoles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Anti Fungal Drugs Market, By Indication, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Aspergillosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Dermatophytosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Candidiasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Mucormycosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Anti Fungal Drugs Market, By Dosage Form, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Powders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Injections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Anti Fungal Drugs Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Anti Fungal Drugs Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Bayer AG
    • Abbott Laboratories
    • Merck & Co., Inc
    • Glenmark Pharmaceuticals Limited
    • Enzon Pharmaceuticals, Inc
    • Pfizer Inc
    • Gilead Sciences, Inc
    • Sanofi S.A.
    • Astellas Pharma, Inc
    • Alembic Pharmaceuticals Limited
    • SCYNEXIS, Inc

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact